Related Experiment Video
Updated: Mar 24, 2026
07:09
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
2.5K
Biomarkers in heart failure with preserved ejection fraction
W C Meijers1, A R van der Velde1, R A de Boer2
1Department of Cardiology, University Medical Center, University of Groningen, Groningen, The Netherlands.
Summary
This study highlights the limited research on biomarkers for heart failure with preserved ejection fraction (HFpEF). It reviews current understanding and emerging biomarkers crucial for diagnosing and managing this common condition.
Area of Science:
- Cardiology
- Biomarker Research
- Heart Failure Management
Background:
- Biomarkers are extensively studied in heart failure, predominantly in patients with reduced ejection fraction (HFrEF).
- There is a significant data gap regarding biomarker utility, dynamics, and biological relevance in heart failure with preserved ejection fraction (HFpEF).
- HFpEF represents a frequent and clinically significant patient population often underrepresented in research.
Purpose of the Study:
- To discuss the value and application of various biomarkers specifically in HFpEF.
- To provide insights into natriuretic peptide measurements for HFpEF diagnosis, prognosis, and risk prediction.
- To explore emerging and recently discovered biomarkers relevant to HFpEF.
Main Methods:
- Review of existing literature on biomarkers in HFpEF.
- Analysis of natriuretic peptide data in HFpEF patients.
- Discussion of novel biomarkers including galectin-3, suppression of tumorigenicity 2 (ST2), growth differentiation factor-15 (GDF-15), and syndecan-1.
Main Results:
- Natriuretic peptides show utility in HFpEF diagnosis, prognosis, and risk stratification.
- Emerging biomarkers like galectin-3 and ST2 offer additional prognostic information.
- Newer biomarkers such as GDF-15 and syndecan-1 are being investigated for their role in HFpEF.
Conclusions:
- There is a critical need for more research on biomarkers in HFpEF.
- Understanding biomarker profiles in HFpEF is essential for improving patient care.
- Novel biomarkers hold promise for enhancing the diagnosis and management of HFpEF.
More Related Videos
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
736
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
736
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
01:29Heart Failure II: Pathophysiology
1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
01:17Pathophysiology of Heart Failure
4.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
01:26Heart Failure III: Clinical Manifestations
830
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
830
01:30Heart Failure IV: Classification and Diagnostic Evaluation
574
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
574